A Phase 1 Study of Neoadjuvant Cabozantinib in Combination With Radiation Therapy for Sarcomas of the Extremities
In this phase 1 trial, concurrent cabozantinib/RT was feasible and demonstrated an acceptable safety profile for patients with extremity STS.
Authors
- Rylee Johnson
- Stephanie K. Schaub (ORCID: https://orcid.org/0000-0002-5148-379X)
- Michael J. Wagner (ORCID: https://orcid.org/0000-0002-8812-1653)
- Munther Baroudi
- Elyse J. Brinkmann (ORCID: https://orcid.org/0000-0002-4489-8321)
- Elizabeth T. Loggers (ORCID: https://orcid.org/0000-0003-3432-0443)
- Edward Kim (ORCID: https://orcid.org/0000-0002-7171-0224)
- Lee Cranmer
- Roxanne Moore
- Jesse L. Roberts
- Niall Morin
- Ted Gooley
- Matthew Thompson
- Hannah R. Abrams
Institutions
- Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa (ZA)
- University of Washington (US)
- City of Hope (US)
- Dana-Farber Cancer Institute (US)
- Clinical Research Management (US)
Publication Details
- Journal
- American Journal of Clinical Oncology
- Published
- 2026-02-23
- DOI
- https://doi.org/10.1097/coc.0000000000001311
- Primary Topic
- Sarcoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00